Protein transport across the endoplasmic reticulum membrane can occur by two pathways, a co-and a post-translational one. In both cases, polypeptides are first targeted to translocation sites in the membrane by virtue of their signal sequences and then transported across or inserted into the phospholipid bilayer, most likely through a protein-conducting channel. Key components of the translocation apparatus have now been identified and the translocation pathways Seem likely to be related to each other but mechanistically distinct. Protein transport across the bacterial inner membrane is both similar to and different from the process in eukaryotes. Other pathways of protein translocation exist that bypass the ones involving classical signal sequences.
INTRODUCTION
In this review we attempt a survey of the processes of protein translocation into the endoplasmic reticulum (ER) of eukaryotes and across the cytoplasmic membrane of bacteria. The major focus is on the phase of translocation during which a polypeptide chain is actually transferred across the membrane. For many years this phase was a black box, but recently key components of the translocation apparatus have been identified, and the mechanistic details of the process are being unraveled. This article is written almost exactly 20 years after the proposal of the signal hypothesis by Blobel & Dobberstein (1). It is now clear that many of the predictions made at the time were correct, in particular the major one: Signal sequences direct nascent polypeptides to the ER membrane where they are further elongated by membrane-bound ribosomes and simultaneously transported across the membrane through an aqueous channel formed from membrane proteins. However, it is now also clear that there exist post-translational pathways of protein translocation that share important features with the cotranslational one, but differ from it in other ways. Perhaps one of the most gratifying discoveries during the past several years is that basic features of the translocation machineries are similar in organisms ranging from bacteria to man. Therefore we try to integrate the information on different systems into a coherent picture at the risk of an occasional oversimplification. We concentrate on the transport of proteins that are completely transferred across the membrane, such as secretory proteins, but also include a section on the integration of membrane proteins. In addition, we give a brief summary of other pathways that bypass the one involving classical signal sequences. This review is not comprehensive; rather, it focuses on unresolved questions and recent developments. Other reviews on the subject (2-9), in particular the excellent review by Walter & Johnson (3), deal with early events of the transport process, emphasizing the targeting pathway involving the signal recognition particle (SRF').
PROTEIN TARGETING
In all eukaryotes there are two pathways, a co-and a post-translational one, by which proteins are transported across the ER membrane or are integrated into Annual Reviews www.annualreviews.org/aronline it. In the cotranslational pathway, transport occurs while the polypeptide chain is being synthesized on a membrane-bound ribosome; in the post-translational pathway, the polypeptide chain is completed in the cytoplasm before being transported. In bacteria, ribosomes do not seem to be tightly bound to the membrane and most proteins may be transported post-translationally, or at least after much of the chain has been synthesized (10) . Both translocation modes require that polypeptides destined for translocation or integration be specifically targeted to the membrane. This process is best understood for the cotranslational pathway in mammals (3); here we give only a short summary with special reference to recent developments.
The cotranslational targeting process is initiated when the signal sequence in a nascent polypeptide chain has emerged from the ribosome and SRP is bound ( Figure 1 , step 1). SRP binds to the signal sequence through the methionine-rich M-domain of its 54 kDa subunit (SRP54) which also contains a second domain (the G-domain) with a GTP-binding site (1 1-16). While bound to the signal sequence, SRP also interacts directly with the ribosome (17), and this interaction increases the affinity of SRP54 for GTP (step 2); the ribosome thus serves as a "GTP-loading factor" (G Bacher, H Luetcke, B Jungnickel, TA Rapoport & B Dobberstein, unpublished). In the next step of the targeting process, the entire complex consisting of the ribosome, the nascent chain, and SRP (containing bound GTP) binds to the ER membrane (step 3). This binding involves two distinct interactions, one between SRP and its membrane receptor (also called docking protein) (18, 19) , and one between the ribosome and ER membrane proteins. The a subunit of the SRP receptor (SRa) interacts in its GTP-bound form with SRP. The latter is released from both the signal sequence and the ribosome (step 4) (20) (21) (22) (23) , and the nascent chain is transferred into the membrane. SRP remains bound to its receptor until, upon GTP-hydrolysis, it is released into the cytosol and can begin a new targeting cycle (step 5 ) (24, 25) . The precise order of hydrolysis of the GTP-molecules bound to SRP54 and to SRa is unknown as yet, but it is likely that SRP54 and SRa act as "GTPase-activating proteins (GAPS)" for each other (24, 26, 27) .
The fact that the ribosome shows a direct interaction with ER membrane proteins poses a conceptual problem: How can one explain that only SRP-containing complexes are targeted to the translocation site? Recent observations suggest that a protein complex, called "nascent polypeptide-associated complex" (NAC) (28), serves as an inhibitor for the SRP-independent interaction of the ribosome with the ER membrane (29) (30) (31) . NAC can be removed from the ribosomes by salt washing; its readdition was found to restore SRP dependence and to prevent membrane binding of ribosome-nascent chain complexes that lack signal sequences (30) . NAC has also been proposed to prevent the interaction of SRP with nascent chains lacking signal sequences; if NAC is removed from the ribosomes by a high-salt wash, SRP can interact with Figure I The SRP cycle. The scheme shows the first steps in cotranslational protein translocation across the ER membrane (for details and references, see text). When the signal sequence of a growing polypeptide chain has emerged from the ribosome, SRP is bound to both the nascent chain and the ribosome (step 1). In step 2, GDP bound to SRP54 is replaced by GTP. In step 3, the SRP-ribosome-nascent chain complex binds to the ER membrane by interactions with both the SRP receptor (in the GTP bound form) and the Sec6lp complex. In step 4, SRP is released from both the signal sequence and the ribosome, and the membrane-bound ribosome-nascent chain complex can begin the actual translocation phase (see Figure 3) . In step 5, GTP is hydrolyzed in both SRP and its receptor. SRP is released and can begin a new cycle. NAC may play a role in these processes by preventing ribosomes that synthesize nascent polypeptide chains lacking signal sequences from interacting with SRP and the Sec6lp complex (not shown).
such nascent chains and targeting occurs (28). Thus, both proposed functions of NAC would prevent the indiscriminate targeting of polypeptide chains to the ER membrane.
An SRP-dependent targeting pathway is found in all eukaryotes but may be utilized to varying degrees. S. cerevisiue mutants lacking SRP or SRP receptor are viable, although they grow poorly (32, 33). These same deletions in other yeasts are lethal. Obviously, alternative targeting pathways must exist at least in S. cerevisiue, and they probably exist in other organisms as well. One possibility is that in the absence of the SRP pathway, the translating ribosome could bind directly to the ER membrane. However, some proteins can be Although the exact relationship among various targeting pathways is still unclear, SRP likely has the fist "pick." SRP samples nascent chains for the presence of signal sequences by interacting with ribosomes at a discrete step of the elongation cycle of translation (36). Properties of the signal sequence, such as its hydrophobicity and charge distribution, may determine how efficiently SRP can interact with the growing nascent chain. Since the affinity of the signal sequence for SRP decreases with chain length (41), there is only a certain "time-window'' during which SRP can bind and target polypeptides to the ER membrane (42, 43). As a result, some proteins might miss the chance to interact with SRP while they are being synthesized and therefore would require a post-translational pathway. Interestingly, recent results indicate that a homolog of SRP54 in the stroma of chloroplasts, 54CP, can function posttranslationally to target some precursor proteins into the thylakoid membrane
(44).
Learning what sequence features 54CP recognizes and how it differs from the mammalian and yeast SRP will be very interesting.
Multiple targeting pathways also exist in Escherichia coli and other bacteria. An SRP-like particle and a homolog of the SRP receptor are involved in the translocation of a subset of proteins (45-48), but the majority of exported proteins in E. coli use a pathway mediated by the cytoplasmic chaperone SecBp (49-51). Although SecBp may interact with the signal sequence (52, 52a), other evidence indicates that it recognizes mostly internal regions of the precursor polypeptide chain (53, 54). Therefore, properties of the polypeptide other than the presence of a cleavable signal sequence may distinguish exported from nonexported proteins. Indeed, in an E. coli strain carrying a mutation that was selected to allow the export of proteins with defective signal sequences, alkaline phosphatase and several other proteins can be translocated even if their signal sequence is completely deleted, whereas cytosolic proteins remain intracellular (55). Secretion of alkaline phosphatase is normally independent of SecBp but becomes dependent on it in the mutant strain. One possible explanation for these surprising results is that exported proteins in E. coli generally fold more slowly than cytosolic ones, allowing them to interact with the chaperone SecBp (55). The presence of a signal sequence may further slow the folding process so that the interaction with SecBp becomes more efficient (56, 57).
COMPONENTS OF THE TRANSLOCATION APPARATUS
After targeting, polypeptides are transported through the membrane at specific translocation sites, also called translocons (58). These are complex structures consisting of several proteins with different functions. It is likely that only some of the components are directly involved in the translocation process, the others being required for chemical modification or folding of the translocating polypeptide chain. In this section, we list the known components of the translocation site and discuss their structural features, synthesizing our knowledge of analogous components in different organisms.
The Sec6lp/SecYEGp Complex
All classes of organisms contain a heterotrimeric complex of membrane proteins, called Sec6lp complex in eukaryotes and SecYEGp complex in prokaryotes, that appears to be a key component of the protein translocation apparatus. The a subunit of the eukaryotic complex was first discovered in S.
cerevisiue in genetic screens for translocation defects and termed Sec6lp (59).
Sec6lp is encoded by an essential gene, and the strongest temperature-sensitive alleles affect the translocation of all proteins tested at nonpermissive conditions (60). A mammalian homolog of Sec6lp was foundSec61a (61Fwhose amino acid sequence is 56% identical to that of the yeast protein. In addition, both proteins have significant sequence similarity with SecYp of bacteria, the first member of this family to be identified (62). All 3 proteins have identical topologies; they each contain 10 membrane-spanning segments (Figure 2) (63, 61; B Wilkinson & C Stirling, personal communication) . SecYp is likely to be a major component of the protein export apparatus in E. coli since it has appeared in several genetic selection schemes (7). Furthermore, the trimeric complexes from mammals and from E. coli have been demonstrated to be essential for the translocation of polypeptides into reconstituted proteoliposomes (64-66). However, it has also been reported that SecYp is not required for protein translocation in a reconstituted system (67, 68).
The smallest subunit of the trimeric complex is called Sec6ly in mammals, Ssslp in S. cerevisiue and SecEp in bacteria. The mammalian Sec6ly is highly related to Ssslp, a protein originally found as a suppressor of temperature-sensitive mutations in Sec6lp (69), and it can replace Ssslp functionally in yeast cells (70) . Both proteins span the membrane once via a segment close to the C terminus (Figure 2) . SecEp is also a single-spanning protein in most bacteria (see 70); in E. coli, however, it has three membrane-spanning regions ( Figure   Annual Recent results indicate that ER membranes of S. cerevisiae contain a second trimeric complex related to the Sec6lp complex, the Sshlp complex (72a).
The a subunit, Sshlp, shares about 35% overall amino acid identity with Sec6lp and has the same predicted membrane topology. The p subunit, Sbh2p, is a close homolog of Sbhlp, and the y subunit, Ssslp, is common to both trimeric complexes. The Sshlp complex is presumed to function exclusively in the cotranslational pathway of protein transport.
Mammalian cells also have a second transcribed gene coding for a highly homologous Sec61-protein (in this case the identity is higher than 95%) (61), but whether the protein is expressed is unknown.
The Signal Recognition Particle Receptor
The SRP receptor in mammals consists of two subunits (76) that are both GTPases (21, 26, 77) . The a subunit was discovered by proteolytic dissection of the mammalian ER membrane (78, 79), and it is responsible for the interaction with SRP during the targeting process (18, 19) . The a subunit is not a bona fide membrane protein, as it can be extracted under conditions that would not solubilize integral membrane proteins. It is most likely anchored to the membrane via the p subunit which is a classical membrane protein (Figure 2) (80). S. cerevisiue has homologs of both subunits (33, 77) , whereas E. coli apparently has only a homolog of the a subunit, called FtsY (45, 46) . The latter is, however, a soluble protein or peripheral membrane protein.
The Translocating-Chain Associating Membrane Protein
The translocating-chain associating membrane (TRAM) protein has been detected in chemical crosslinking experiments designed to identify membrane Annual Reviews www.annualreviews.org/aronline proteins that are in proximity to short nascent polypeptide chains after their transfer from SRP into the mammalian ER membrane (81). Upon purification, TRAM was shown to be required for the cotranslational translocation of most, but not all, polypeptides into reconstituted proteoliposomes (64, 81). So far, homologs of TRAM have only been discovered in organisms as divergent as Cuenorhubditis eleguns. TRAM is a glycoprotein, has 6 or 8 predicted membrane-spanning segments and a cytoplasmic, C-terminal tail of about 60 residues (Figure 2 ) (81).
The Sec62/Sec63p Complex
The Sec62lSec63p complex contains four subunits: Sec62p, Sec63p, Sec7lp, and Sec72p. In yeast microsomes, this complex is found associated with the trimeric Sec6lp complex to form a heptameric Sec complex (72). However, it may also exist as a separate entity since the large Sec complex can be readily dissociated in vitro (72) and a sub-complex of the Sec62/Sec63p complex can be purified (82). Sec62p and Sec63p were detected in Saccharomyces cerevisiue in genetic screens for translocation components (59, 83-85). They are encoded by essential genes and span the ER membrane two and three times, respectively (Figure 2 ). Both proteins have extended C-terminal, cytoplasmic domains. Sec63p has a lumenal domain that is homologous to the J-domain of the E. coli chaperone DnaJ (85); it is via this domain that DnaJ interacts with its partner DnaK. Similarly, in the lumen of the ER, Sec63p interacts through its J-domain with the lumenal chaperone Kar2p (BiP) (86,87), another member of the Hsp70 family to which DnaK belongs.
Sec7 lp and Sec72p were found in genetic screens for translocation components (88, 89), as well as by biochemical methods (originally called Sec66p and Sec67p, respectively), as associated proteins of . Sec7lp is a glycoprotein that spans the membrane once; Sec72p is a peripheral membrane protein located on the cytoplasmic side of the ER membrane ( Figure 2) . Deletion of the gene for Sec7lp leads to the additional absence of Sec72p (93), suggesting that these two proteins interact with each other in the complex. In the deletion mutant, a translocation defect is seen but the growth of the cells is only affected at elevated temperatures. Deletion mutants of SEC72 do not show any growth defects (91, 93). A role for the constituents of the Sec6Y63p complex in translocation has also been demonstrated in vitro by the use of reconstituted systems (72, 82, 94) .
Homologs of Sec62p and probably of Sec63p exist in higher eukaryotes (95, 96). The SEC62 gene of Drosophila can functionally replace the corresponding gene in yeast (96). Interestingly, the level of expression of the gene in Drosophila varies among different tissues.
Some mutations in components of the Sec62/Sec63p complex of S. cereAnnual Reviews www.annualreviews.org/aronline visiae show strong unexpected defects in nuclear protein localization karyogamy or DNA-replication [Sec63p = npll(85); Sec7lp, Sec72p (94); Sec72p = sim2 (232)l. The same is true for Kar2p (97). Although these mutations may affect the ER membrane translocation of one or more proteins involved in these nuclear processes and thus exert indirect effects, another possibility is that the complex has functions in addition to that in protein transport.
Kar2p (BiP)
A role for the ER-lumenal chaperone Kar2p in translocation is indicated by genetic data that show a rapid appearance of translocation defects in temperature-sensitive mutants at nonpermissive temperatures (98), as well as by the stimulatory effect of Kar2p on in vitro translocation (72, 82, 99) . Kar2p is a soluble ATPase that can interact with the J-domain of Sec63p (86, 87). Kar2p has been reported to copunfy with Sec63p under certain conditions and to dissociate from it upon addition of the ATP-analog ATPyS (82).
The SecA Protein
SecAp is a key component of the translocation apparatus in E. coli and other bacteria (100). It has been detected in various genetic screens for translocation components and is an essential component for the translocation of proteins in bacterial in vitro assays (7, 65, 66) . Homologs in eukaryotes have only been found in chloroplasts (101). SecAp is detected in E. coli as a homodimer (102) both in the cytoplasmic compartment and bound to the cytoplasmic membrane (103). It is an ATPase, and each monomer contains two ATP-binding sites (104, 105). SecAp has affinities for the cytoplasmic chaperone SecBp, for the signal sequence and mature region of precursor polypeptide chains, for acidic phospholipids in the membrane, and for the SecYEGp complex (103, 104, 1 06).
The SecD/SecFp Complex
SecD and SecF have been found in genetic screens in E. coli (107, 108) and are also present in other bacteria, but apparently not in Mycoplasma genitalium, the free-living organism with the smallest known genome (108a). Deletion of the genes of SecD and SecF in E. coli leads to growth and translocation defects, but the cells are still viable (109). SecD and SecF are also not required for the translocation of proteins into reconstituted proteoliposomes (65, 66). The proteins are related to each other, form a complex, and are coexpressed (108) . Both are predicted to span the cytoplasmic membrane six times ( Figure 2 ).
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Enzymes in the Translocation Site
In eukaryotes, the translocation site appears to contain two enzymes that catalyze cotranslocational modifications of polypeptide chains: the signal p e p tidase and the oligosaccharyltransferase. Neither is essential for the translocation process per se (81). Both are unusual enzymes in that they are as abundant as their substrates, probably reflecting the fact that they are located in each translocation site so that they may act on nascent chains as they emerge into the lumen of the ER. In addition, both enzymes are surprisingly complex, each containing several polypeptide subunits. The signal peptidase generally cleaves at a site that has small aliphatic residues at positions -1 and -3 (110). In mammals, the signal peptidase is a complex of five different membrane proteins (1 11). Two of the subunits, SP18 and SP21, span the membrane once and have sequence similarity to the yeast protein Secllp and to the bacterial signal (leader) peptidase Leplp (1 12, 113). They each contain an active site that includes an essential serine residue (1 14). The other subunits are SP22/23, a glycoprotein with the same membrane topology as SP18 and SP21 (113, 115) , and SP25 and SP12, which span the membrane twice with both their N-and C-terminal domains in the cytoplasm and little of their sequence exposed to the lumen (1 16, 116a). These subunits are unlikely to play a role in the enzymatic reaction; they could perhaps be involved in interactions with components of the translocation site. The signal peptidase in S. cerevisiue is similarly complex (1 17), but is less well characterized. In bacteria, the signal (leader) peptidase consists of only one subunit that spans the membrane twice with closely spaced membrane anchors (1 18). The eukaryotic multisubunit signal peptidases may have aquired multiple catalytic subunits to broaden their range of substrate specificity. This possibility is suggested by the fact that the signal peptidase in the inner membrane of mitochondria of S. cerevisiue is a complex that contains two catalytic subunits with nonoverlapping substrate specificities (1 19).
The oligosaccharyltransferase protein transfers an oligosaccharyl moiety from the dolichol intermediate to Asn-residues located in the sequence context Asn-X-Ser or Thr (with X being any amino acid other than Pro). Glycosylation occurs when this site has reached a distance of at least 12 amino acids from the plane of the lumenal side of the membrane (120). The enzyme has been characterized both in mammals and yeast; it does not exist in bacteria. Three subunits (ribophorin I, ribophorin 11, and Ost48) have been identified in the mammalian enzyme (121) but there are probably more. In S. cerevisiae, the enzyme can be purified as a complex of at least six subunits (122). Genetic experiments have revealed that several of the subunits have a role in N-glycosylation in vivo (123-127). The largest a subunit (Ostl) is a homolog of ribophorin I (125), the p subunit (Wbpl) of Ost48 (128), and the 6 subunit Annual Reviews www.annualreviews.org/aronline (Swpl) of ribophorin I1 (122). All these proteins span the membrane once. The 'y-and &-subunits (Ost3 and Ost2, respectively) span the membrane four and three times, respectively (126, 127). The sequence of an additional small subunit is unknown as yet. Genetic evidence suggests that Stop, a protein not copurified with the yeast enzyme complex, is also required in vivo for the activity of the oligosaccharyl transferase (129). So far, the precise function of any of these proteins is only poorly understood.
Other Components
Several other components have been implicated in the translocation process or are assumed to be present at the translocation site. The membrane protein p180 has been proposed as a ribosome receptor in the cotranslational translocation process (13O-132), but arguments have been raised against its suggested role (133, 233) . The data on whether it is essential for translocation in reconstituted systems conflict (64, 131). p180 may perhaps provide "storage sites" for ribosomes not engaged in translocation (132) . Another membrane protein, p34, also has been proposed as a ribosome receptor (134, 135) , but again counterarguments have been raised (133) . Further components with unknown functions include the heterotetrameric translocon associated-protein (TRAP) com-plex, previously called signal-sequence receptor (SSR) (136), and RAMP4, a small protein with affinity for ribosomes (64). As judged from results with reconstituted systems (64, 72, 137) , none of these components appears to be absolutely essential for translocation of the proteins tested thus far.
MECHANISTIC ASPECTS OF PROTEIN TRANSLOCATION
A Protein-Conducting Channel
It was postulated long ago that a protein-conducting channel in the membrane is transiently formed or opened so that a polypeptide chain can move across the phospholipid bilayer (1). Such a channel must exist for both co-and post-translational translocation pathways although the detailed mechanism by which the polypeptide chain is transferred through it may differ. Initial evidence for a channel came from the observation that translocating proteins can be extracted from the membrane by aqueous perturbants (138). More direct evidence for proteinconducting channels in the cotranslational mode of protein transport was provided by electrophysiological experiments. Simon & Blobel (139) fused rough microsomes into planar lipids and demonstrated that a large number of ion-conducting channels appear when the nascent chains are released from the membrane-bound ribosomes by treatment with the drug puromycin. Presumably the channels were previously plugged by polypeptide Annual Reviews www.annualreviews.org/aronline chains in transit through the membrane. The channels close when the salt concentration is subsequently raised, causing the ribosomes to detach from the membrane. These conditions are thought to mimic the physiological termination of translation. Using the same methodology, evidence was provided for the existence of ion-conducting channels in the cytoplasmic membrane of E. coli that open upon addition of synthetic signal peptides (140). These conditions may imitate the post-translational pathway and suggest again the existence of a protein-conducting channel that is gated by the signal sequence.
Strong support for such hydrophilic protein-conducting channels during cotranslational translocation comes from experiments in which fluorescent probes are incorporated into translocating nascent chains of the secretory protein preprolactin (141, 142). Measurements of the fluorescent life-time of the probes indicate an aqueous environment inside the membrane. The probes cannot be quenched by iodide ions added to the cytoplasmic compartment, indicating that the ribosome makes a tight seal with the membrane. When the membrane is treated with streptolysin 0 to allow passage of the iodide ions through the bilayer into the lumenal compartment, the probes can be quenched even if they are located in the portion of the nascent chain expected to be inside the ribosome. These data suggest that a contiguous hydrophilic channel reaches from the lumen of the ER all the way up into the ribosome. If the nascent chains contain fewer than 64 amino acid residues, the iodide ions cannot enter the channel from the lumen of the ER (142), indicating that a certain polypeptide chain length is required to open the channel toward the lumen.
The protein-conducting channel must be different from a channel that transports small molecules because it must open in two dimensions: perpendicular to the membrane to let hydrophilic polypeptide chains across, and within the plane of the membrane to let hydrophobic anchors of membrane proteins into the phospholipid bilayer (139, 143) . Recent data indeed show that the channel has an interface with the lipid: Photoreactive probes, incorporated into the hydrophobic portions of either a membrane anchor of a membrane protein or the signal sequence of a secretory protein, can react both with protein components of the translocation apparatus and with lipids (144).
Cotranslational Translocation
The translocation apparatus involved in cotranslational protein transport has been best characterized in the mammalian system. Following the key observation that translocation-active proteoliposomes can be produced from crude detergent extracts of dog pancreatic microsomes (145), a reconstituted system consisting only of highly purified membrane proteins was developed (64). Surprisingly, proteoliposomes containing only three components-the SRP Annual Reviews www.annualreviews.org/aronline receptor, the Sec6lp complex, and the TRAM protein-are competent to translocate all proteins tested so far (the TRAM protein is dispensable for some proteins, see below). Although these three components constitute the minimum translocation apparatus in the membrane, additional factors may be required to stimulate or regulate the process. Also, because cotranslational translocation is studied with crude in vitro translation systems, cytosolic proteins in addition to SRP and NAC could play a role.
The molecular mechanism of cotranslational translocation and the specific functions of components of the minimum translocation apparatus are only now being unraveled. Most mechanistic studies make use of defined translocation intermediates which are produced by translating truncated mRNAs in vitro in the presence of SRP and microsomal membranes; this yields ribosome-bound nascent chains of varying length that are caught at different stages of their transfer through the membrane (146).
The first step following the targeting by SRP is the binding of the ribosomenascent chain complex to the translocation site of the ER membrane ( Figure  3 , stage 1 to stage 2). An interaction of the nascent chain with the translocation site can already be observed with short polypeptides in which the signal sequence has just emerged from the ribosome and is thus able to interact with the SRP (in the case of the secretory protein preprolactin at a chain length of 51 to 64 residues). At this stage, the ribosome-nascent chain complex can be extracted from the membrane at high salt concentrations, indicative of an electrostatic interaction (147) (Figure 3, stage 2) . The nascent chain is also susceptible to externally added protease (28). This initial weak membrane contact of the ribosome-nascent chain complex is most likely caused by a direct binding of the ribosome to Sec6lp. When ribosome-nascent chain complexes are targeted by SFW, only the SFW-receptor and the Sec6lp complex are required in the membrane to transfer the nascent chain from SRP into the vicinity of Sec6la (28). Ribosome-nascent chain complexes that are washed with high salt and can therefore be targeted in the absence of the SRP/SRPreceptor system (28-30) require only the Sec6lp complex for membrane binding (28). This salt-sensitive interaction is probably also the basis for the specific binding to microsomes of ribosomes lacking nascent chains altogether (148). When the latter are incubated with proteoliposomes reconstituted from crude detergent extracts of microsomes, they bind at physiological salt concentrations (150 mM) almost exclusively to the Sec6lp complex (133) . At lower salt concentrations, however, nonspecific ribosome binding to other proteins may occur, explaining the conflicting reports on different ribosome receptors (130, 131, (133) (134) (135) .
Clearly distinct from this initial weak membrane interaction of the ribosome-nascent chain complex is the much stronger membrane association that occurs when the polypeptide chain becomes longer (in the case of preprolactin, Annual Reviews www.annualreviews.org/aronline Figure 1) . At stage 2, the nascent chain is transferred into the membrane and the ribosome is bound loosely to the Sec6 Ip complex. At this point, the signal sequence may contact either only the Sec6lp complex (model a) or both the protein and lipids (model b). Following further chain elongation, the nascent polypeptide adopts a loop structure and its signal sequence is recognized in a process that involves the Sec6 Ip complex (and the TRAM protein in the case of TRAM-dependent proteins). At this point (stage 3), the nascent chain is productively inserted into the translocation site, its signal sequence contacts the TRAM protein, the ribosome is firmly bound to the Sec6lp complex, and the protein-conducting channel is open towards the lumen. At stage 4, the signal sequence has been cleavedoff, theTRAM protein is not in immediate proximity of the nascent chain anymore, and the nascent chain has adopted a transmembrane orientation. The elongating polypeptide chain is transferred across a contiguous channel extending from the ribosome through the tightly linked Sec6lp complex. Annual Reviews www.annualreviews.org/aronline longer than 70 residues) ( Figure 3, beginning with stage 3) . This form of binding is not solely due to electrostatic interactions because even at high salt concentrations the nascent chains cannot be extracted from the membrane (28, 138, 147). The Sec6lp complex must mediate this interaction as well since ribosome-nascent chain complexes targeted by SRP are bound in a salt-resistant manner to proteoliposomes containing only the SRP receptor and the Sec6lp complex (28). Consistent with this assumption, the Sec6lp complex remains bound to ribosomes at high salt concentrations after solubilization of rough microsomes in mild detergents, and this tight interaction is induced when a nascent chain is targeted by SRP to the ER membrane (61).
A tight seal between the ribosome and the membrane at this stage of translocation is also suggested by the finding that the nascent chain is now resistant to proteolysis (146) even if the membranes are solubilized before addition of the protease (146, 149). The membrane component responsible for shielding the polypeptide chain must be the Sec6lp complex because in proteoliposomes it alone suffices to obtain full protection against proteolysis (28). Conversely, membrane-bound ribosomes in rough microsomes efficiently protect Sec6la from proteolytic attack (133) . The tight membrane interaction is also characterized by the fact that the removal of ribosomes from the membrane requires both the release of the nascent chain from the ribosome by puromycin and high salt concentrations (150), conditions that lead to the dissociation of the ribosome into its two subunits and may therefore mimic physiological termination of translation. The same conditions are required to dissociate the solubilized ribosome-Sec6lp complex (61) and to close the protein-conducting channel in the electrophysiological experiments (139). Taken together, the increase in the affinity of the ribosome for the Sec6lp complex must be caused directly or indirectly by the ribosome-bound nascent polypeptide chain that is deeply inserted into the membrane.
The critical transition from the weak to the tight interaction of the ribosome-nascent chain complex with the membrane requires a functional signal sequence in the nascent chain (28). Strikingly, the chain length at which preprolactin attains resistance to treatment with high salt or protease (28) is the same as that required in the fluorescence quenching experiments for the opening of the protein-conducting channel towards the lumen of the ER (142). It is therefore likely that the signal sequence gates the protein-conducting channel. For the translocation substrate preprolactin, the only protein component required in the phospholipid bilayer to discriminate a functional from a nonfunctional signal sequence is the Sec6lp complex (28). The fact that the polypeptide chain must be about 15 amino acids longer for signal recognition in the membrane than for its efficient interaction with the SRP suggests that the nascent chain inserts into the translocation site in a loop structure, in agreement with other data (151, 152) ; apparently the signal sequence must Annual Reviews www.annualreviews.org/aronline PROTEIN TRANSLOCATION 287 have emerged sufficiently from the ribosome in order to reach its binding site within the membrane. Whether the signal sequence enters the translocation site laterally through the lipid phase or directly from the cytoplasm through a proteinaceous environment (Figure 3, stages 2a or 2b) is still unknown. It is therefore not clear whether functional and nonfunctional signal sequences are discriminated by a protein-protein interaction with the Sec6lp complex or by their ability to partition into the lipid phase, as demonstrated for synthetic signal peptides (153, 154). It is also possible that both membrane components are involved. After insertion into the translocation site, the hydrophobic core of the signal sequence is in contact with both Sec6la and lipid (stage 3) (la), whereas the N-terminal portion of the signal sequence is located in an aqueous environment (141).
Even though the entire translocation process and all individual steps analyzed are faithfully reproduced in the defined reconstituted system, it is possible that in this system the channel would be constantly open so that gating would not be required. In a physiological situation, the channel could be plugged by a "gating factor" (142) whose removal may be triggered by the interaction of the signal sequence with the Sec6lp complex. Such a gating process could involve the function of BiPand of otherlumenal proteins, providing an explanation as to why these proteins are not required for translocation in reconstituted systems (64) as they appear to be in native microsomes (155).
The insertion of the nascent chain of most secretory proteins into the translocation site requires, in addition to the Sec6lp complex, the presence of the TRAM protein in proteoliposomes (S Voigt, B Jungnickel, E Hartmann & TA Rapoport, unpublished 
observations). Preprolactin is one of the few tested proteins that can be transported into reconstituted vesicles lacking TRAM (64).
A signal sequence-exchange experiment carried out with preprolactin and prepro-&factor, a TRAM-dependent secretory protein, indicates that the differing behavior of these proteins is due entirely to the structure of their signal sequences (S Voigt, B Jungnickel, E Hartmann & TA Rapoport, unpublished observations). The role TRAM plays in the process of signal sequence recognition of TRAM-dependent proteins is still unknown. Crosslinking experiments performed with preprolactin show that TRAM contacts the N-terminal domain of the signal sequence (152,156) once the nascent chain is productively inserted into the translocation site (28).
The existence of two consecutive signal-sequence recognition events during cotranslational translocation, one in the cytosol by the SRP and one in the membrane, may increase the fidelity of the process. The hydrophobicity of the signal sequence is likely the decisive feature recognized in both steps, but more subtle differences in specificity may also exist. If the same features were recognized, however, an increased fidelity of signal sequence recognition would only be expected if a kinetic proofreading step existed that actively Annual Reviews www.annualreviews.org/aronline discarded mistargeted polypeptides, an effect for which there is no evidence. Another reason for a second signal sequence recognition step in the membrane may be to serve as the point at which different targeting pathways merge. The signal sequence-gated opening of the translocation channel could indeed be the common denominator of all co-and post-translational transport pathways.
Once the nascent polypeptide chain has been inserted into the translocation site, it may be committed to translocation but there appear to be further distinct steps in the process. One step has been identified as being sensitive to treatment with N-ethylmaleimide (157) and another by the return of protease sensitivity to the nascent chain when it exceeds a length of about 100 residues (146). The initiation phase is probably only completed when the signal sequence has been cleaved off by the signal peptidase and the polypeptide has adopted a transmembrane orientation [which occurs for preprolactin when the chain reaches a length of about 140 residues (S Voigt & TA Rapoport, unpublished observations)] (Figure 3, stage 4) . At this point, TRAM can no longer be crosslinked to the nascent polypeptide chain (152).
Although no direct evidence yet shows that the Sec6lp complex forms a protein-conducting channel, numerous crosslinking studies with various proteins have demonstrated that Sec6la is in spatial proximity to translocating polypeptide chains throughout the translocation process (61, 152, 156, (158) (159) (160) . For preprolactin chains that have adopted a transmembrane orientation after signal peptide cleavage, systematic, site-specific crosslinking experiments have shown that Sec6la contacts each of the approximately 40 consecutive amino acid residues of the nascent chain that directly precede the region of about 30 residues buried inside the ribosome (152). No major crosslinks are observed from amino acid residues in this region to other membrane proteins suggesting that these do not have easy lateral access to the polypeptide chain as it passes through the membrane. Taking into account the data from electrophysiological, fluorescence, and biochemical approaches, it seems likely that during the cotranslational translocation process the elongating nascent polypeptide chain is transferred directly from a channel in the ribosome into a Sec6lp-channel in the membrane (see Figure 3, stage 4) . No pushing or pulling machinery has to be invoked; the growing nascent chain has only one way out of the extended channel (3,61,64). In addition, the tight coupling of the ribosome channel with the membrane channel prevents both the folding of the polypeptide chain into a translocation-incompetent conformation and the passage of other molecules through the membrane.
The final step in the process of cotranslational translocation is likely to be coupled to the termination of translation. Upon amval at the stop codon, the C-terminal 30 residues that are still in the ribosome must be transferred across the membrane, the channel must close, and the ribosome must detach from the membrane. The details of these events have not yet been analyzed.
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Post-Translational Translocation in Yeast
The mechanism of post-translational protein transport across the ER membrane must differ in fundamental aspects from that of the cotranslational pathway. In the post-translational pathway the ribosome obviously does not play a role, and vectorial synthesis of the polypeptide chain cannot be the mechanism by which directionality of protein transport across the membrane is achieved. Whereas in the cotranslational pathway the ribosome makes a tight seal with the membrane and thus prevents the leakage of molecules through it (141). the membrane barrier must be maintained by alternative means during posttranslational translocation. Also, as discussed above, the mechanisms of targeting to the ER membrane are likely to be different for the two pathways.
Post-translational protein translocation across the ER membrane has been best studied in S. cerevisiae. In contrast to microsomes from dog pancreas, those from yeast can transport the secretory protein prepro-a-factor in vitro in a post-translational manner (161-la), suggesting that they contain translucation components required for the post-translational mode which the canine microsomes seem to lack. The distinction is not absolute, however, since mammalian microsomes can transport some proteins, mostly small ones, in a post-translational manner (165-167), and yeast microsomes can transport some proteins only cotranslationally (34) .
Post-translational protein translocation in yeast can be reproduced with reconstituted proteoliposomes containing a purified complex of seven proteins, the SIX complex, which is composed of the trimeric Sec6lp complex (Sec6lp, Sbhlp, and Ssslp) and the tetrameric Sec62/Sec63p complex (Sec62p. Sec63p, Sec7 lp, and Sec72p) (72). With in vitro-synthesized prepro-a-factor as a translocation substrate, about 10-20% of the molecules are translocated into the reconstituted vesicles as demonstrated by the fact that they become resistant to externally added protease. When dissociated, neither of the two subcomplexes shows significant translocation activity when reconstituted alone, but the activity is restored to the original level if they are recombined. Inclusion of Kar2p into the lumen of reconstituted vesicles and addition of ATP stimulates the rate and extent of translocation of prepro-a-factor by a factor of 3-5 (72), consistent with previous reports that showed an important role for this chaperone in protein translocation in vivo and in vitro (82, 98, 99) . While the addition of Kar2p and ATP exerts only a stimulatory effect in the case of prepro-a-factor, these factors are essential for the translocation of proOmpA, a bacterial protein that can be post-translationally transported into yeast microsomes (168).
These and other results suggest a model for the mechanism of post-translational protein transport, but it is still largely hypothetical and based in some respects on analogy with the cotranslational pathway (Figure 4) . Presumably, Annual Reviews www.annualreviews.org/aronline the completed polypeptide chain is presented to the ER membrane in a complex with cytosolic proteins, particularly with chaperones, and these must be released before translocation can occur. A component of the Sec complex or Ydjlp, a Dnd-homolog bound to the ER membrane via a farnesyl chain (40), could interact with the chaperones and release them from the precursor polypeptide. The polypeptide chain would then bind to the Sec complex in the membrane and adopt a loop structure (Figure 4, step 1) . The components that recognize the signal sequence are unknown. Sec72p could be one receptor (91), but Sec62p [which appears to function prior to Sec6lp (169, 170) ] and the constituents of the trimeric Sec6lp complex (in analogy to the mammalian system) could also be involved in signal sequence recognition. Following the insertion of the protein into the translocation site, the signal sequence would be held in place by an interaction with its receptor while the C-terminal portion of the hairpin formed by the polypeptide chain could slide back and forth through the protein-conducting channel ( Figure 4 , step 2). When a portion of the chain arrives on the lumenal side of the membrane, Kadp could bind to it. This binding requires the prior interaction of Kar2p with the Dnd-domain of the Sec63p subunit (82, 85-87). Upon ATP-hydrolysis, Kadp in its ADP-bound form would be associated with the polypeptide chain, thereby preventing its retrograde movement through the translocation channel (step 3). According to this model, Kar2p in conjunction with Sec63p would function as a molecular ratchet (171). In this way the model would be similar to one suggested for the import of proteins into the matrix of mitochondria (172-174) in which mt-Hsp70, a homolog of Kar2p in the mitochondrial matrix, cooperates with the inner membrane protein MIM44fisp45 in an ATP-dependent manner. This model could also explain the basal level of transport seen for prepro-a-factor in the reconstituted system lacking Kar2p and ATP (72), i.e. the C-terminus of some prepro-afactor molecules may reach the lumenal side of the membrane by passively sliding through the channel. However, in the case of proOmpA, folding on the cytoplasmic side may prevent its passive sliding; therefore binding to Kar2p on the lumenal side would be required either to pull the polypeptide chain across the membrane or merely to shift the equilibrium towards the lumen of the ER.
Kar2p may have an additional function earlier in the translocation process: In microsomes isolated from certain temperature-sensitive mutants, the insertion of prepro-a-factor into the translocation site, determined by its crosslinking to Sec6lp, is prevented at nonpermissive temperatures (170). Perhaps Kar2p is involved in an early gating step during which the translocation channel would be opened in an ATP-dependent manner by the signal sequence. If one assumes that the channel is constantly open in reconstituted proteoliposomes, this would also explain why, in contrast to native microsomes, they can Annual Reviews www.annualreviews.org/aronline . In step 1, the completed polypeptide chain is inserted in a loop structure into the translocation site formed from the Sec-complex (which consists of the Sec6lp-and Sec62/63p subcomplexes). In step 2, the C-terminal portion of the hairpin formed by the polypeptide chain can slide back and forth through the protein-conducting channel, but once on the lumenal side, Kar2p can bind to the incoming chain. This process involves an ATP-dependent interaction of Kar2p with the J-domain of the Sec63p subunit of the Sec complex. In step 3, upon ATP-hydrolysis, Kar2p binds to the polypeptide chain and prevents its retrograde movement through the protein-conducting channel.
transport prepro-a-factor in the absence of ATP (72). As discussed above, the function of Kar2p (BiP) in gating might also be required in cotranslational translocation, providing an explanation for its recently reported involvement in this pathway (170a).
Given the fact that all membrane proteins identified in S. cerevisiue in genetic screens for translocation components are contained in the heptameric Sec complex, and that the latter consists exclusively of them (plus the novel Sbhl-protein) (72), the Sec complex likely represents a functional unit that is involved in vivo in post-translational protein transport. In support of this assumption, the Sec complex shows little association with ribosomes upon solubilization of rough microsomes (72). In contrast, the trimeric Sec6lp complex that also exists as a separate entity in yeast microsomes, has an affinity to ribosomes like its counterpart in mammals and is therefore presumably involved in cotranslational translocation. It seems possible that the translocation apparatus is a dynamic assembly of building blocks, with the trimeric Sec6lp complex as the core of the machinery. In the cotranslational pathway it would cooperate with the SRP receptor and perhaps with a homolog of the TRAM protein, and in the post-translational pathway with the Sec6USec63p complex and Kar2p. Indeed, proteins whose translocation is blocked in certain mutants of Sec62p and Sec63p are not affected in mutants of a SRP subunit, Annual Reviews www.annualreviews.org/aronline and conversely, proteins impeded most severely in SRP mutants are insensitive to mutations in the Sec62 and S a 6 3 proteins (32, 83; P Walter, personal communication) . These results suggest that the Sec62/Sec63p complex and SRP function in vivo in distinct pathways, although there may be some "crosstalk" between the two. By analogy to the role of the SRP pathway, one may hypothesize that the Sec62ISec63p complex is involved in the targeting process during post-translational transport, although in this case the targeting complex would remain bound to the core complex and therefore be part of each translocation site. Crosslinking experiments have indeed provided evidence that Sec62p functions prior to Sec6lp during the post-translational translocation of prepro-a-factor (169, 170).
Post-Translational Translocation in Escherichia coli
Protein transport across the cytoplasmic membrane in E. coli, and probably other bacteria, not only is triggered by signal sequences that are similar to and exchangeable with those in eukaryotic proteins, but also involves the trimeric SecYEGp complex that is structurally related to the eukaryotic Sec6lp complex (70). Like its homolog in eukaryotes, the SecYEGp complex is believed to form a protein-conducting channel (175). Despite. these similarities, however, the molecular mechanisms of protein transport must be significantly different. In bacteria, no homologs of the Sa62/Sec63p complex or of Kar2p (BiP) are known, and a molecular ratchet mechanism involving these components cannot be responsible for providing the driving force in the prevailing post-translational mode of protein transport. Instead, bacteria possess an essential ATPase-SecApin the cytoplasmic compartment and inner membrane. Obviously, the location of the two ATPases, SecAp and Kar2p, on opposite sides of the membrane in prokaryotic and eukaryotic organisms implies entirely different mechanisms for the coupling of ATP-hydrolysis with protein transport (2).
Much of our knowledge of the details of protein transport in E. coli comes from the fact that efficient translocation of the protein proOmpA can be reproduced in a completely reconstituted system consisting of purified precursor protein, the cytosolic chaperone SecBp, the "translocation ATPase'' SecAp, and proteoliposomes containing the SecYEGp complex (65, 66, 176) . These and other in vitro experiments (103, (177) (178) (179) have led to a model depicted in Figure 5 . The first step in the translocation process is the interaction of the polypeptide chain with SecBp in the cytoplasm. Next, the polypeptide is transferred to SecAp bound to the membrane (step 2). This high-affinity interaction of SecAp with the membrane involves both the SecYEGp complex and acidic phospholipids (1 80), and it is required to activate SecAp for binding the preprotein-SecBp complex (103). With its N-terminal domain SecAp recognizes the signal sequence but also interacts with the mature part of the preprotein (104, 106, 181) . ATP-binding to Annual Reviews www.annualreviews.org/aronline Figure 5 Model for post-translational protein transport in bacteria (for details, see text). In step 1, the completed polypeptide binds to the cytosolic chaperone SecBp. In step 2, the resulting complex associates with SecAp that is prebound to the SecYEGp complex in the cytoplasmic membrane. In step 3, SecAp inserts itself into the membrane, taking with it a bound stretch of the polypeptide chain of about 20 amino acids. Upon hydrolysis of ATP (step 4), SecAp releases the bound polypeptide and withdraws from the membrane. This cycle is repeated (steps 4 and 5 ) and the polypeptide chain is thereby transported one stretch at a time. The transport reaction can also be driven by the membrane potential once the polypeptidechain has been inserted into the translocation and is relased from SecAp (step 6).
the N-terminal nucleotide binding site of SecAp (1 82) then activates the protein to insert itself deeply into the membrane so that it actually reaches the periplasmic side even though it does not contain any long hydrophobic stretches of amino acids (179, 183, 183a) (step 3). During its membrane insertion, SecAp takes about 20 residues of the bound polypeptide chain with it into the membrane (177). Based on analogy with the mammalian Sec6lp complex (28) and on the identification of signal sequence suppressor mutants in constituents of the SecYEGp complex (184, 185). it appears possible that the signal sequence is again recognized or proofread in the membrane. Upon ATP-hydrolysis, SecAp releases the polypeptide chain and comes out of the membrane (179, 183a) but remains bound to the SecYEGp complex (step 4). It is then able to start a new cycle of binding about 20 residues of the translocating polypeptide chain and bringing them into the membrane (steps 4 and 5). This process is repeated until the polypeptide has completely crossed the membrane. Such a "plunging" model would explain the translocation of the polypeptide chain in discrete portions (1 77), but the present evidence does not completely exclude an alternative model in which SecAp would remain in the membrane until the polypeptide chain is completely across.
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The electrochemical potential across the cytoplasmic membrane is an alternative energy source that can provide the driving force for translocation (1 86) ( Figure 5, step 6 ). It appears that the potential-dependent mechanism can be replaced by the SecApdependent one in vitro (177), but it is essential in vivo (187). The molecular basis for the effect of the membrane potential is still poorly understood; it does not seem to be a simple electrophoretic effect (188). The presence of a membrane potential decreases the number of ATP molecules hydrolyzed by SecAp per molecule of protein transported, and it may counteract the retrograde movement of the polypeptide chain when SecAp is released from it (177).
The SecD/SecFp complex likely plays a facilitating role in the outlined translocation process. Several functions have been proposed and need to be further explored: coupling the membrane potential across the cytoplasmic membrane with the translocation machinery (189), release of polypeptide chains from the translocation site into the periplasmic space (190) , and regulation of the membrane insertion of SecAp (183, 183a) . Genetic experiments indicate an interaction between the SecD/SecFp complex and SecYp (191, 192) , suggesting that the components cooperate during the translocation process.
INSERTION OF MEMBRANE PROTEINS
The membrane insertion of many proteins occurs through the same targeting and translocation machinery used for the translocation of secretory proteins (64, 158, [193] [194] [195] [196] [197] [198] [199] , but the molecular mechanism is still poorly understood.
Reconstituted proteoliposomes containing the components of the minimum translocation apparatus of the mammalian ER membrane are able to insert at least single-spanning membrane proteins of all classes (64, 196). Thus, the Sec6lp complex and the TRAM protein alone in the phospholipid bilayer must suffice to recognize hydrophobic segments of the nascent polypeptide chain as stop-transfer sequences and to achieve their correct orientation. Post-translational insertion of membrane proteins in eukaryotes may occur (200, 201) but has not been studied in any detail. In E. coli, some proteins of the cytoplasmic membrane use the SecYp-dependent pathway for their insertion (202, 203) , but others, like the M13 phage coat protein, can insert post-translationally into membranes lacking the normal translocation machinery or even into protein-free liposomes (204).
A major question is at which point membrane anchors of a nascent membrane protein leave the translocation site to become embedded into the phospholipid bilayer. In vitro experiments, camed out with short N-terminal fragments of a eukaryotic membrane protein whose uncleaved signal sequence serves as the single membrane anchor (signal-anchor protein), demonstrate that the hydrophobic segment can be crosslinked to both Sec6la and lipids at Annual Reviews www.annualreviews.org/aronline PROTEIN TRANSLOCATION 295 early phases of translocation (144). Thus, the anchor seems to be located at the interface between the two. The precise location of the signal anchor in the translocation site may differ from that of a cleavable signal sequence (205). The complete release of the signal anchor from the channel into the lipid phase requires polypeptide-chain termination (144). A similar conclusion was reached in experiments with a polypeptide that has a cleavable signal sequence and a succeeding membrane anchor; crosslinks to proteins of the translocation site are seen even if the polypeptide segment following the anchor is as long as 100 residues, but they disappear upon chain termination (206). It would be of great interest to know whether the anchors of multi-spanning membrane proteins leave the translocation channel during the translation process. If so, they may either leave in a consecutive manner by being displaced from the interface site and pushed out into the lipid phase when the next anchor arrives, or two successive anchors could be transiently "stored" at the interphase site, or all anchors may be "stored" and only released upon polypeptide chain termination (207; S Simon, personal communication).
Another unresolved issue is how the correct orientation of a membrane protein is achieved (207a). In a cotranslational translocation process, the orientation of the first hydrophobic segment, be it a cleavable signal sequence or an uncleaved anchor, may determine the orientation of all subsequent membrane anchors. One predictive rule for the orientation of this first segment is that the flanking region with the more positive net charge is located in the cytoplasm (208). In some cases, however, the membrane anchors have an inherent preferred orientation regardless of their position in a polypeptide chain (209). In bacteria, the "positive inside rule" predicts that the loops between membrane anchors containing the highest number of positively charged residues (neglecting the negatively charged ones) will be cytoplasmic (210). It appears that cytoplasmic loops are the prime determinants for the orientation of membrane anchors in multi-spanning membrane proteins in E. coli and that, if these signals are conflicting with each other, the proteins may adopt topologies that leave out potential membrane anchors (21 1, 212). The correct topology with positive charges remaining in the cytosol requires an intact electrochemical potential across the cytoplasmic membrane (21 3). Such a mechanism is unlikely to play a role in eukaryotes because the ER membrane lacks a significant electrochemical potential.
OTHER TRANSLOCATION PATHWAYS
Both prokaryotes and eukaryotes contain several secretory and membrane proteins that do not have classical signal sequences and that bypass the general Sec-protein-dependent translocation machineries to reach the same final destinations, i.e. locations outside the cell or in membranes of the secretory pathway.
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One example of a nonclassical translocation pathway involves ABC (ATP--binding cassette)-transporters (also called traffic ATPases) (for review, see 214-216). These transporters are a ubiquitous family of membrane proteins consisting of four domains: two membrane spanning domains (typically containing six membrane-spanning segments each) and two cytoplasmic ATPbinding domains (see 217,218). The latter couple ATP-hydrolysis to transport of the specific substrate across the membrane. The mechanism is best understood for the secretion of the 1 10 kDa protein hemolysin (HlyA) from E. coli. In addition to the ABC-transporter HlyB, located in the inner membrane, at least two additional proteins are required to transport the protein through both membranes: HlyD in the inner membrane (which may, however, span the periplasmic space) and TolC in the outer membrane. The secretion signal for hemolysin is contained in its C-terminal 60 amino acids; this region is both necessary and sufficient for the export of hemolysin or of chimeric proteins.
In other bacteria, transport of members of the metalloprotease family by ABC-transporters also requires a signal at their C-terminus. In this case, a Dxxx-motif (with x being hydrophobic residues) is necessary, though not sufficient, for secretion (219). One possibility is that the secretion signal is formed by a (rather imperfect) amphipathic helix (215). The hydrophobic face of this helix may direct the protein molecule to the membrane where it could interact with the ABC-transporter. Such an interaction may be enhanced by the observed post-translational attachment of a fatty acid to hemolysin, although this modification is not essential for secretion (220). An initial interaction of substrates of ABC-transporters with lipid has been suggested in other cases as well (221), but specificity must also require substrate binding to the transporter. The hydrophobic substrates could laterally enter the translocation channel that is presumably formed from the membrane-spanning segments of the transporter (222). Such a model is reminiscent of one proposed for classical translocation pathways in which the signal sequence would enter the translocation channel laterally (see Figure 3 , model b). More hydrophilic substrates, however, are probably bound directly from the aqueous phase to ABC-transporters. In any case, it is still unclear precisely how the substrate is recognized, how ATP-hydrolysis is coupled to protein transport, and how directionality of translocation is achieved. Hopefully, the study of other ABC-transporters that transport small peptides, such as the Ste6 protein from S. cerevisiae (see 223) or the TAP transporter in mammals (see 224), will help to simplify the analysis of these systems.
Another even less characterized nonclassical transport system is the secretion of certain proteins, such as interleukins IL-la and -lb, basic and acidic fibroblast growth factors, and transglutaminase in eukaryotes (for review, see 2 18, 225). These proteins lack hydrophobic signal sequences and evidently do not follow the classical secretory pathway; they are not glycosylated even Annual Reviews www.annualreviews.org/aronline though they contain potential N-glycosylation sites, their transport cannot be blocked when vesicular transport is inhibited by the drug brefeldin A, and they are not found associated with membranes of the secretory pathway. In each case the secretory proteins are found inside the cell in rather high concentrations before export (for review, see 225). Quantitative export of the basic fibroblast growth factor has been observed in an energy-dependent reaction (234). The interleukin 1 polypeptides are synthesized as larger precursors which are then further processed and modified by attachment of a fatty acid molecule before secretion. These features are reminiscent of those of a-factor, the peptide substrate of the ABC-transporter Ste6 in yeast (223), and it has been speculated that interleukin 1 may be exported by a related system (225).
Another nonclassical pathway is used to insert a class of membrane proteins into phospholipid bilayers which have an N-terminal cytoplasmic domain and possess a C-terminal membrane anchor ("tail-anchored" membrane proteins) (226). These proteins do not contain hydrophobic signal sequences and their membrane anchor is so close to the C-terminus that it remains buried in the ribosome when termination of translation occurs; membrane insertion must therefore be post-translational. Tail-anchored proteins are found in various organelles of the secretory pathway. Examples include cytochrome b5, protein tyrosine phosphatase lB, heme oxygenase, resident in the ER, and a large number of SNARE proteins, located in various transport vesicles and target membranes (226). On the basis of in vitro results with cytochrome bS, these proteins were initially believed to be able to insert indiscriminately into all membranes [for references, see (226)l. However, cytochrome b5 specifically inserts into the ER in vivo (227, 228). Furthermore, several proteins have been shown to first insert into the ER membrane and subsequently be transported along the secretory pathway to their various destinations. These include synaptobrevin, a protein in synaptic vesicles, the yeast protein Sso2p, a homolog of syntaxin in the plasma membrane, and giantin, a Golgi protein (229-231). If vesicular transport is inhibited by brefeldin A, the proteins stay in the ER, indicating that only this membrane has the capacity to incorporate them.
Recent in vitro experiments carried out with synaptobrevin indicate that its insertion into the mammalian ER membrane is ATP-dependent and greatly stimulated by a trypsin-sensitive factor in the membrane (230). Proteoliposomes depleted of the Sec6lp complex remain competent for membrane insertion, whereas proteoliposomes containing the purified SRP receptor, the Sec6lp complex, and the TRAM protein are inactive. These results indicate that the Sec6lp complex is not required and that at least one membrane protein is involved in the insertion process that differs from the known mammalian translocation components (230).
CONCLUSIONS AND PERSPECTIVES
With the progress of recent years, several important issues in the field of protein translocation have been clarified. The existence of a protein-conducting channel now seems likely, and most essential membranecomponents of the translocation machineries of the co-and post-translational pathways may have been identified. Both basic similarities and fundamental differences have emerged for the pathways in various classes of organisms. Major questions now on the agenda concern the molecular mechanism of the translocation process. How is the protein-conducting channel gated? How is loop-insertion of a polypeptide chain into the translocation site achieved? Is there a proofreading mechanism for signal sequences? How is the translocation process regulated? How precisely is ATP-hydrolysis coupled to translocation in the post-translational pathways?
The answers to these and other questions may well lead to the discovery of additional translocation factors and to the identification of a function for components that are known to exist but have been ignored in the current mechanistic models. Despite a general conservation of basic features of the translocation process, different cell types could vary in their content of translocation components or may contain different isoforms of them, and the process may be more subject to fine regulation than hitherto appreciated. Novel assays, biophysical methods, and their combination with established reconstituted systems, as well as structural studies on the purified translocation Components will be required to address the mechanistic problems.
The biosynthesis of membrane proteins also clearly still presents a particular enigma. It is more hypothesis than fact that the protein-conducting channel opens laterally toward the lipid to let membrane anchors out, and neither the point at which this occurs nor the mechanism by which the orientation of a membrane protein is achieved are known. Finally, the analysis of nonclassical translocation pathways may well lead to the discovery of entirely novel mechanisms by which proteins insert into or cross membranes.
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